MedTrace Logo

Hemopatch as a Tool to Prevent Biliary Fistula in Liver Surgery.

NCT03993067 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2021-04-06

No results posted yet for this study

Summary

The aim of the study is to investigate the use of Hemopatch to prevent biliary fistula in patients submitted to surgery for malignancy.

Conditions

  • Biliary Fistula
  • Surgery

Interventions

PROCEDURE

Hemopatch

Hemopatch is a collagen based sealant is a hemostat agent. We want to investigate his role in the prevention of post operative biliary fistula

PROCEDURE

Fribrin glue and Tabotamp

Fibrin glue and Tabotampis the standard treatment

Sponsors & Collaborators

  • University of Milan

    lead OTHER

Principal Investigators

  • Guido Torzilli · Department of Biomedical Sciences Humanitas University, Milan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-15
Primary Completion
2020-01-15
Completion
2020-01-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03993067 on ClinicalTrials.gov